Injective Price Tests Key Resistance, Bullish Crossover Supports Ongoing Upward Movement.

Injective (INJ) is showing signs of recovery after testing a low of $5.00 in April. The price is currently testing the upper channel resistance and has sustained above the 9-day and 21-day EMAs, reinforcing bullish strength. The MACD is also showing a bullish crossover, supporting the ongoing upward movement. Potential targets for INJ include $12.50, $15.00, and $26 zones.

Injective (INJ) has demonstrated signs of recovery after reaching a low of $5.00 in April. The cryptocurrency is currently testing the upper channel resistance and has sustained above the 9-day and 21-day Exponential Moving Averages (EMAs), reinforcing bullish strength. The MACD indicator has also shown a bullish crossover, further supporting the ongoing upward movement. Potential targets for INJ include $12.50, $15.00, and $26 zones [1].

The recovery of INJ follows a period of low bearish sentiment, which has been evident in the recent past. Institutional investors have shown significant interest in the Open Network (TON), contributing to bullish sentiment. The TON/USD pair has not yet broken out of crucial resistance levels, but it has formed a potential reversal pattern characterized by a double bottom and rising divergence of the Relative Strength Index (RSI) [1]. This pattern, coupled with bullish signals from the MACD indicator, suggests that TON is well-positioned to rally towards the next liquidity range between $4.6 and $7.2, given that it consistently closes above the daily logarithmic trend.

Additionally, the TON ecosystem's integration with the Telegram messaging platform has attracted new customers, further boosting its potential. The low percentage of TON coin holders currently in profit (20%) indicates a high chance of bullish sentiment ahead [1]. The Open Network has grown to a robust blockchain ecosystem with over 400 node validators and a total value locked of about $138 million, backed by top-tier venture capital firms and global liquidity expansion [1].

In another significant development, MGX Investments has announced a $2 billion investment in Binance, signaling major institutional confidence in the exchange. This capital injection has sparked intense market speculation about the potential listing of a new stablecoin, USD1, on Binance. The fully diluted valuation (FDV) of USD1 has already surpassed that of FDUSD, positioning it as a potential game-changer in the stablecoin sector [2]. The involvement of the Trump family and WLFI in the crypto sector could further drive retail sentiment, potentially inflating trading volumes for Binance-listed assets.

For traders, these developments present opportunities in stablecoin-related pairs such as BTC/USD1 or ETH/USD1 if the token is listed. Increased liquidity could reduce slippage and enhance arbitrage opportunities. The involvement of the Trump family and WLFI could also indirectly boost AI-related tokens, which often correlate with market sentiment shifts.

In summary, Injective (INJ) is showing signs of recovery with bullish indicators supporting its upward movement. The potential targets for INJ include $12.50, $15.00, and $26 zones. The developments surrounding Binance and the potential listing of USD1 also present new trading opportunities for investors.

References:
[1] https://coinpedia.org/price-analysis/ton-price-analysis-today-key-short-term-targets-for-april-2025/
[2] https://blockchain.news/flashnews/mgx-invests-2-billion-in-binance-usd1-fdv-surpasses-fdusd-trump-family-wlfi-join-crypto-push